No Data
No Data
Express News | Watching Petros Pharmaceuticals; Shares Trading Higher, Company Files Amended S-1 Filing
Petros Pharmaceuticals Files to Sell Units, No Amount Given
Retros Pharmaceuticals Shares Are Trading Higher After the Company Announced It's in a Position to Lead the Rx-To-OTC Switch Market With Its Proprietary AI and Quantum Computing Platform.
Express News | Petros Pharmaceuticals Positioned To Lead Rx-To-OTC Switch Market With Proprietary AI And Quantum Computing Platform Following FDA Approval Of New ACNU Rule; Aims To Expand Consumer Access Through Innovative Self-Care Solutions
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader From Newly Approved FDA OTC Final Rules
Maxim Group Keeps Their Buy Rating on Petros Pharmaceuticals (PTPI)
Unlock the Full List